10/10/2014 - 1:22pm

The Food and Drug Administration on Friday approved Akynzeo (netupitant and palonosetron) for the treatment of nausea and vomiting in patients who are undergoing cancer chemotherapy.

10/09/2014 - 2:49pm

Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.

10/09/2014 - 2:13pm

Salix Pharmaceuticals on Thursday announced that the Food and Drug Administration granted final approval for the company's Uceris (budesonide) rectal foam for patients with mild-to-moderate distal ulcerative colitis. 

10/08/2014 - 10:59am

Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. 

10/07/2014 - 11:52am

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

10/07/2014 - 9:47am

Sandoz announced the launch of its dexmedetomidine hydrochloride injection, a generic version of Precedex from Hospira. 

10/07/2014 - 9:04am

Omron Healthcare on Tuesday introduced a new line of monitors that provide even more accurate results, according to the company. 

10/06/2014 - 11:43am

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

10/06/2014 - 10:09am

UrgentRx on Monday announced the expansion of its product line to include UrgentRx Fast Powders 10-count multipack boxes of its single-dose packets for a variety of common ailments.